Inventor · disambiguated record
Janusz Czernielewski
Also filed as: CZERNIELEWSKI JANUSZ
15 granted patents·4 pending applications·98 citations·filing 1995–2022
93Inventor score
Top patents by PatentIndex Score
19 records- 0189US8703820B2Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGRAEBER MICHAEL·Filed 2010·Granted Apr 22, 2014·7 cites·20 claims
- 0289US7579377B2Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGALDERMA RES & DEV·Filed 2004·Granted Aug 25, 2009·17 cites·3 claims
- 0388US8729127B2Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGRAEBER MICHAEL·Filed 2011·Granted May 20, 2014·6 cites·16 claims
- 0486US9622994B2Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acidGALDERMA RES & DEV·Filed 2014·Granted Apr 18, 2017·4 cites·40 claims
- 0585US9387187B2Administration of 6[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGALDERMA RES & DEV·Filed 2014·Granted Jul 12, 2016·3 cites·21 claims
- 0684US9381179B2Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGALDERMA RES & DEV·Filed 2014·Granted Jul 5, 2016·3 cites·6 claims
- 0784US7834060B2Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoic acid for the treatment of dermatological disordersGALDERMA RES & DEV·Filed 2009·Granted Nov 16, 2010·3 cites·35 claims
- 0884US7737181B2Pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGALDERMA RES & DEV·Filed 2006·Granted Jun 15, 2010·3 cites·36 claims
- 0982US7838558B2Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGALDERMA RES & DEV·Filed 2008·Granted Nov 23, 2010·2 cites·15 claims
- 1080US7868044B2Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acidGALDERMA RES & DEV·Filed 2010·Granted Jan 11, 2011·2 cites·41 claims
- 1179US5849776AMedicaments based on metronidazole or on a synergic mixture of metronidazole and clindamycinCIRD GALDERMA·Filed 1995·Granted Dec 15, 1998·46 cites·14 claims
- 1277US8653140B2Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGRAEBER MICHAEL·Filed 2012·Granted Feb 18, 2014·1 cites·13 claims
- 1376US8921423B2Method for the treatment of acne using compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acidGRAEBER MICHAEL·Filed 2010·Granted Dec 30, 2014·1 cites·36 claims
- 1469US2018104203A1Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGALDERMA RES & DEV·Filed 2017·Application pending·0 cites
- 1567US2017181991A1Method for the treatment of acne using pharmaceutical compositions comprising 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acidGALDERMA RES & DEV·Filed 2017·Application pending·0 cites
- 1666US9901556B2Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGALDERMA RES & DEV·Filed 2016·Granted Feb 27, 2018·0 cites·20 claims
- 1766US9872842B2Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disordersGALDERMA RES & DEV·Filed 2016·Granted Jan 23, 2018·0 cites·5 claims
- 1859US2024100045A1Emulsion composition and uses thereof in the prevention and/or treatment of skin damage caused by radiationTARIAN PHARMA·Filed 2022·Application pending·0 cites
- 1959US2024100044A1Hydrogel composition and uses thereof in the prevention and/or treatment of skin damage caused by radiationTARIAN PHARMA·Filed 2022·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →